跳至主要内容
临床试验/EUCTR2013-000370-30-SE
EUCTR2013-000370-30-SE进行中(未招募)不适用

Diagnosis and follow up of neuroendocrine tumours with 68Ga-DotaToc PET/CT

orrlands University Hospital0 个研究点开始时间: 2015年7月7日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with high suspicion of or with known neuroendocrine tumors are included and a base-line PET/CT is done for staging and depiction of the primary tumor is done. Patients with known neuroendocrine tumors with suspected recurrence is included and a PET/CT is done for evaluation. Patients with an accidentally diagnosed neuroendocrine tumor at surgery for other diagnoses are included after primary surgery and a PET/CT is done for staging.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 30
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 30

排除标准

  • Age < 18 years

研究者

发起方
orrlands University Hospital

相似试验